Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19
NCT05226546
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Anosmia
COVID-19
Interventions
DRUG:
Platelet rich plasma (PRP)
OTHER:
olfactory training
Sponsor
Centre Hospitalier Universitaire Saint Pierre